Andreas Pinter

Feb 7, 2024 | nejm.org | Robert Bissonnette |Andreas Pinter |Laura K. Ferris |Ronald Vender

February 8, 2024N Engl J Med 2024; 390:510-521 DOI: 10.1056/NEJMoa2308713 AbstractThe use of monoclonal antibodies has changed the treatment of several immune-mediated inflammatory diseases, including psoriasis. However, these large proteins must be administered by injection. JNJ-77242113 is a novel, orally administered interleukin-23–receptor antagonist peptide that selectively blocks interleukin-23 signaling and downstream cytokine production.

Oct 17, 2023 | bpno.dk | Andreas Pinter

oktober 2023 With the interests of long term management and the prevention of comorbidty developments in patients, dermatologist Andreas Pinter from the University Hospital in Frankfurt, discusses the new and promising treatments for psoriasis, including topical, oral medications, and nanobodies.